BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18382618)

  • 1. Intracellular signalling by C-peptide.
    Hills CE; Brunskill NJ
    Exp Diabetes Res; 2008; 2008():635158. PubMed ID: 18382618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological effects of C-peptide].
    Tsimaratos M
    Nephrologie; 2004; 25(5):155-61. PubMed ID: 15455788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular effects of C-peptide--new perspectives on an old peptide.
    Wahren J; Shafqat J; Johansson J; Chibalin A; Ekberg K; Jörnvall H
    Exp Diabesity Res; 2004; 5(1):15-23. PubMed ID: 15198368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide stimulates Na+, K+-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells.
    Zhong Z; Kotova O; Davidescu A; Ehrén I; Ekberg K; Jörnvall H; Wahren J; Chibalin AV
    Cell Mol Life Sci; 2004 Nov; 61(21):2782-90. PubMed ID: 15549182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells.
    Zhong Z; Davidescu A; Ehrén I; Ekberg K; Jörnvall H; Wahren J; Chibalin AV
    Diabetologia; 2005 Jan; 48(1):187-97. PubMed ID: 15624099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological effects of proinsulin C-peptide].
    Kimura K
    Seikagaku; 2005 May; 77(5):419-23. PubMed ID: 15952332
    [No Abstract]   [Full Text] [Related]  

  • 7. C-peptide as a therapeutic tool in diabetic nephropathy.
    Hills CE; Brunskill NJ; Squires PE
    Am J Nephrol; 2010; 31(5):389-97. PubMed ID: 20357430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide makes a comeback.
    Wahren J; Jörnvall H
    Diabetes Metab Res Rev; 2003; 19(5):345-7. PubMed ID: 12951641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
    Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats.
    Kitamura T; Kimura K; Makondo K; Furuya DT; Suzuki M; Yoshida T; Saito M
    Diabetologia; 2003 Dec; 46(12):1698-705. PubMed ID: 14586499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats.
    Nordquist L; Shimada K; Ishii T; Furuya DT; Kamikawa A; Kimura K
    Diabetes Metab Res Rev; 2010 Mar; 26(3):193-9. PubMed ID: 20225182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb.
    Tsimaratos M; Roger F; Chabardès D; Mordasini D; Hasler U; Doucet A; Martin PY; Féraille E
    Diabetologia; 2003 Jan; 46(1):124-31. PubMed ID: 12637991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-peptide: new findings and therapeutic implications in diabetes.
    Wahren J
    Clin Physiol Funct Imaging; 2004 Jul; 24(4):180-9. PubMed ID: 15233831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and physiological effects of C-peptide.
    Hills CE; Brunskill NJ
    Clin Sci (Lond); 2009 Apr; 116(7):565-74. PubMed ID: 19243312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular effects of proinsulin C-peptide.
    Johansson J; Ekberg K; Shafqat J; Henriksson M; Chibalin A; Wahren J; Jörnvall H
    Biochem Biophys Res Commun; 2002 Aug; 295(5):1035-40. PubMed ID: 12135597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
    Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
    Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological effects and therapeutic potential of proinsulin C-peptide.
    Yosten GL; Maric-Bilkan C; Luppi P; Wahren J
    Am J Physiol Endocrinol Metab; 2014 Dec; 307(11):E955-68. PubMed ID: 25249503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of C-peptide in human physiology.
    Wahren J; Ekberg K; Johansson J; Henriksson M; Pramanik A; Johansson BL; Rigler R; Jörnvall H
    Am J Physiol Endocrinol Metab; 2000 May; 278(5):E759-68. PubMed ID: 10780930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide: new findings and therapeutic possibilities.
    Wahren J; Larsson C
    Diabetes Res Clin Pract; 2015 Mar; 107(3):309-19. PubMed ID: 25648391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.